XTAE
HUMX
Market cap1mUSD
Apr 03, Last price
26.80ILS
1D
0.37%
1Q
-15.46%
IPO
-98.92%
Name
Human Xtensions Ltd
Chart & Performance
P/E
—
P/S
144.86
EPS
—
Div Yield, %
—
Shrs. gr., 5y
0.07%
Rev. gr., 5y
%
Revenues
5m
+56.00%
Net income
-37m
L-17.84%
CFO
-34m
L-17.79%
Profile
Human Xtensions Ltd. develops, manufactures, markets and sells a modular medical device for minimally invasive surgical operations. It offers HandX, a handheld electromechanical device for use in laparoscopic procedures; Fenestrated Grasper; Monopolar Hook; and Needle Holder. The company was incorporated in 2012 and is based in Netanya, Israel.
Valuation
Title ILS in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|
| 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | |
| Income | ||||||
Revenues | 4,950 56.00% | 3,173 13.73% | ||||
Cost of revenue | 30,897 | 36,001 | ||||
Unusual Expense (Income) | ||||||
NOPBT | (25,947) | (32,828) | ||||
NOPBT Margin | ||||||
Operating Taxes | 499 | |||||
Tax Rate | ||||||
NOPAT | (25,947) | (33,327) | ||||
Net income | (36,635) -17.84% | (44,592) -16.84% | ||||
Dividends | ||||||
Dividend yield | ||||||
Proceeds from repurchase of equity | ||||||
BB yield | ||||||
| Debt | ||||||
Debt current | 966 | 1,527 | ||||
Long-term debt | 2,414 | 3,815 | ||||
Deferred revenue | 2,559 | |||||
Other long-term liabilities | 2,466 | 2,600 | ||||
Net debt | (21,678) | (54,303) | ||||
| Cash flow | ||||||
Cash from operating activities | (34,306) | (41,731) | ||||
CAPEX | (190) | (440) | ||||
Cash from investing activities | 19,289 | 15,161 | ||||
Cash from financing activities | (1,918) | (2,600) | ||||
FCF | (23,744) | (31,499) | ||||
| Balance | ||||||
Cash | 25,058 | 59,645 | ||||
Long term investments | ||||||
Excess cash | 24,810 | 59,486 | ||||
Stockholders' equity | (301,514) | (264,879) | ||||
Invested Capital | 331,776 | 334,488 | ||||
ROIC | ||||||
ROCE | ||||||
| EV | ||||||
Common stock shares outstanding | 26,756 | 26,756 | ||||
Price | 1.30 83.57% | 0.71 -85.13% | ||||
Market cap | 34,676 83.57% | 18,890 -85.11% | ||||
EV | 12,998 | (35,413) | ||||
EBITDA | (24,038) | (30,065) | ||||
EV/EBITDA | 1.18 | |||||
Interest | 121 | 444 | ||||
Interest/NOPBT | ||||||